T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.55% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.85% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Axsome Therapeutics
AXSM
$11.2B
| $35.5M | ﹤0.01% |
627,338
-411,917
| -40% | -$29M |
|
1127
Lincoln Electric
LECO
$15.6B
| $35.5M | ﹤0.01% |
288,817
-12,235
| -4% | -$1.46M |
|
|
CMLFU
1128
DELISTED
CM Life Sciences, Inc. Unit
CMLFU
| $35.3M | ﹤0.01% |
2,147,854
| – | – |
|
|
SPNS
1129
DELISTED
Sapiens International
SPNS
| $35.3M | ﹤0.01% |
1,108,924
-16,738
| -1% | -$543K |
|
1130
Floor & Decor
FND
$6.32B
| $35.1M | ﹤0.01% |
367,699
+332,176
| +935% | +$32.3M |
|
1131
Nasdaq
NDAQ
$54.6B
| $35.1M | ﹤0.01% |
713,703
-46,842
| -6% | -$2.22M |
|
1132
Southern First Bancshares
SFST
$607M
| $35.1M | ﹤0.01% |
747,743
+204,481
| +38% | +$8.92M |
|
|
HI
1133
DELISTED
Hillenbrand
HI
| $34.9M | ﹤0.01% |
731,163
+60,217
| +9% | +$2.76M |
|
1134
Agnico Eagle Mines
AEM
$91.3B
| $34.6M | ﹤0.01% |
599,402
+99,798
| +20% | +$6.45M |
|
|
OLO
1135
DELISTED
Olo Inc
OLO
| $34.3M | ﹤0.01% |
+1,300,000
| New | +$39.1M |
|
1136
Clearway Energy Class C
CWEN
$7.06B
| $34.2M | ﹤0.01% |
1,215,892
+92,022
| +8% | +$2.83M |
|
1137
Warner Music
WMG
$13.3B
| $34.1M | ﹤0.01% |
993,905
+14,988
| +2% | +$536K |
|
1138
Pegasystems
PEGA
$5.51B
| $34M | ﹤0.01% |
595,044
-606,412
| -50% | -$39.6M |
|
|
PFHD
1139
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $33.8M | ﹤0.01% |
1,840,742
-1,618
| -0.1% | -$27.2K |
|
1140
Hewlett Packard
HPE
$79.2B
| $33.6M | ﹤0.01% |
2,137,831
-112,199
| -5% | -$1.55M |
|
1141
Carnival Corporation Ltd
CCL
$38.9B
| $33.4M | ﹤0.01% |
1,260,158
+16,669
| +1% | +$393K |
|
|
NBP
1142
NovaBridge Biosciences American Depositary Shares
NBP
$216M
| $33.4M | ﹤0.01% |
+688,820
| New | +$37.4M |
|
|
RUTH
1143
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $33.4M | ﹤0.01% |
+1,344,642
| New | +$28.6M |
|
1144
Qorvo
QRVO
$8.67B
| $33.3M | ﹤0.01% |
182,040
-10,649
| -6% | -$1.87M |
|
1145
Goodyear
GT
$1.78B
| $33.1M | ﹤0.01% |
1,883,826
+1,764,625
| +1,480% | +$25.6M |
|
1146
Western Digital
WDC
$168B
| $33M | ﹤0.01% |
654,130
-41,027
| -6% | -$1.92M |
|
1147
Invesco
IVZ
$14.3B
| $33M | ﹤0.01% |
1,307,820
+613,973
| +88% | +$13.8M |
|
1148
Sun Communities
SUI
$14.6B
| $33M | ﹤0.01% |
219,724
-568,685
| -72% | -$84M |
|
1149
Pulmonx
LUNG
$92.8M
| $32.8M | ﹤0.01% |
717,923
+348,008
| +94% | +$20M |
|
1150
Regions Financial
RF
$26.9B
| $32.8M | ﹤0.01% |
1,587,095
-101,059
| -6% | -$1.98M |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.